...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: More Exempt Distribution Investments
Reply New Message
Back To Forum List View
More Exempt Distribution Investments
3
KOO-KOO2
Jan 05, 2024 02:49PM
Re: More Exempt Distribution Investments
1
fuzzyjr
Jan 05, 2024 03:22PM
Re: More Exempt Distribution Investments
1
KOO-KOO2
Jan 05, 2024 03:27PM
Re: More Exempt Distribution Investments

fuzzyjr
Jan 05, 2024 03:37PM
Re: More Exempt Distribution Investments

KOO-KOO2
Jan 05, 2024 04:43PM
Re: More Exempt Distribution Investments

fuzzyjr
Jan 05, 2024 04:47PM
Re: More Exempt Distribution Investments
5
KOO-KOO2
Jan 05, 2024 05:24PM
Re: More Exempt Distribution Investments
1
fuzzyjr
Feb 28, 2024 04:32PM

No! That is a concern.

In 2023 we had consecutive months of exempt distribution financing for Zenith.

The latest one was on January 4th, 2024. Now we're almost 60 days with no financing. 

For Resverlogix, the latest was on May 23, 2023.

 

Koo

3 Recommendations
Re: More Exempt Distribution Investments
4
narmac
Feb 29, 2024 10:38AM
Reply New Message
Back To Forum List View
Share
Share
New Message
Please login to post a reply